Likarda

At Likarda, we’re continually pushing the boundaries of innovation to overcome the logistical challenges of cell therapy delivery. Two standout results of this innovation are AegisCell™ and LiberaCell™. AegisCell™ has remarkable potential to protect cells when they must be frozen for storage. In one of our success stories, fresh blood products stored in AegisCell™ on a cooled gel pack maintained high viability for three weeks—something previously unattainable without this advanced encapsulant. This technology not only extends the shelf life of vital cells but also simplifies storage and transport, making the process safer and more cost-effective. LiberaCell™ further enhances logistics by enabling cells to be shipped on dry ice instead of liquid nitrogen, protecting them from ice crystals during the freeze-thaw process. Both hydrogels start with materials familiar to the FDA that can be customized for all cell types, ensuring safety and flexibility in cell therapy logistics. Talk to us to discover how much you can save by using Likarda and eliminating the need for liquid nitrogen in your shipments at Likarda.com. #celltherapy #celldelivery #biotech #cryopreservation

Is Controlled Delivery the Future of Biologics? As biologics continue to revolutionize modern medicine, effective drug delivery remains a significant challenge. In Likarda’s latest white paper, Jordan R. Hunt, PhD explores how hydrogels are emerging as a key solution, offering protection for sensitive molecules, controlled release kinetics, and improved therapeutic outcomes. The paper also covers the benefits, challenges, and real-world applications of integrating hydrogels with biologics. Stay ahead in biotech innovation—read the full white paper now: https://lnkd.in/dBtgaD7P #Biologics #DrugDelivery #Hydrogels #HealthcareInnovation

We are excited to share that our Founder + President, Lisa Stehno-Bittel, will be featured as a panelist at Evia Bio's upcoming CryoChats™ on Wednesday, October 30th, at 2 PM ET. This month’s discussion will focus on an essential topic: 🧊 Cryopreservation of Cell Aggregates and Spheroids. Joining Lisa to discuss ongoing innovations and challenges of this *cool* technology is an esteemed lineup of experts: 🔹 Allison Hubel, PhD – President of the Society for Cryobiology 🔹 Ben Noren – CEO & Co-Founder at CellDrop Biosciences Hosted by: Jeffrey D. Allen – Chairman & CEO at Evia Bio 🔗 Register now: https://lnkd.in/gUXVHa83 We appreciate the opportunity to be a part of this conversation, and can't wait to see what brilliant ideas come from it! #celltherapy #cryochat #cryopreservation #biotechnology

Take action this week with the United States Bone and Joint Initiative! 🦴 Did you know, bone and joint conditions are the most common cause of severe, long-term pain wordwide. For those suffering from osteoarthritis and other bone health issues, therapies like antibodies and stem cells are promising, but delivering them precisely remains a challenge. Likarda's Core-Shell Spherification (CSS) technology solves this by targeting the right site and ensuring the cells stay where needed, promoting faster healing. Additionally, our ViscoCell™ microbeads provide a breakthrough for joint care, improving outcomes in osteoarthritis and similar conditions. Learn more about the ViscoCell™ and the stunning case study results here: https://lnkd.in/gmq6K4U5 #BoneHealth #Osteoporosis #Osteoarthritis #ViscoCell #Likarda #BoneAndJointActionWeek

Last chance to register for our #LikardaKonnect Webinar – happening tomorrow! Don't miss this opportunity to learn from leading experts in hormone replacement therapy. Join us at 11:00 AM EST tomorrow, October 16th, for a game-changing discussion featuring: - Dr. Charles Virden, CEO of VitalTE, sharing expertise on subcutaneous biomechanics. - Dr. Lisa Stehno-Bittel, Founder of Likarda, discussing innovative hormone delivery technologies. Moderated by Dr. Stella K. Vnook , this webinar will be useful to anyone interested in innovations in this exciting and important industry. Register now before it’s too late: https://lnkd.in/g93iXpPq #hormonehealth #hormonereplacement #healthcareinnovation

Team Likarda supported Stephen Harrington and his family entries in the Lenexa Chili Challenge. It was a great night for Francis Karanu, Kami Olson, Aaron Lehman, Jordan R. Hunt, PhD, Lisa Stehno-Bittel and assorted friends. Congratulations to "Life of the Farty" for FIRST PLACE (out of ~ 160 teams) for their amazing Home Style Chili.

Join Likarda CEO, Stella K. Vnook, at BioFuture 2024 in NYC! BioFuture, hosted by Demy-Colton, is a leading conference bringing together life science innovators, investors, and industry experts to explore the future of biomedicine. This year's event will feature groundbreaking sessions on biotechnology, digital health, and more. We're excited to announce Dr. Vnook will be speaking on a panel focused on Women’s Health. 📅 Wednesday, October 30, 2024 ⏰ 3:00 PM 📍 12th Floor, Dialogue 8A We hope you can join Dr. Vnook for this insightful session! #WomensHealth #BioFuture2024 #BiotechLeaders #Biopharma

Unlock the Future of Therapeutic Delivery at the #PODDConference with Likarda's CEO, Dr. Stella K. Vnook 📅 Monday, October 28, 2024 ⏰ 2:15 PM 📍 Track 4: Precision Drug Delivery Join Stella K. Vnook as she dives into Likarda's Core-Shell Spherification® technology and it's role in transforming therapeutic delivery for cell therapies and biologics. You'll Learn How This Technology Leads To: - Precision-driven therapeutic solutions for optimal efficacy - Innovations enhancing safety and product quality - Advanced techniques for immune protection and cell preservation Take advantage of this opportunity to elevate your drug delivery strategies with cutting-edge expertise from Likarda. #PODD2024 #DrugDelivery #Pharma PODD: Partnership Opportunities in Drug Delivery Community News

Don’t Miss Our Next #LikardaKonnect Webinar! Join us on October 16th at 11:00 AM EST for an in-depth discussion on groundbreaking advancements in hormone replacement therapy that are redefining patient outcomes. We’re excited to host these leading experts in the field: 🔹 Dr. Charles Virden, CEO of VitalTE and a renowned specialist in subcutaneous biomechanics 🔹 Dr. Lisa Stehno-Bittel, Founder of Likarda and leader in advanced drug delivery Moderated by Likarda CEO, Stella K. Vnook, this conversation will cover: 🔸 The future of hormone therapy and what’s driving change in this vital area of patient care 🔸The role of innovative delivery technologies in boosting efficacy and patient experience 📅 Register today: https://lnkd.in/g93iXpPq #HormoneTherapy #HormoneDelivery #DrugDelivery #HealthcareInnovation

Awesome employees doing great work!